LGG Supplementation in Patients With AUD and ALD
Part of paid clinical trials in Louisville, Kentucky.
- Sponsor
- University of Louisville
- Study ID
- NCT05178069
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Alcohol Use Disorder
- Alcohol-associated Liver Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- : Placebo for Probiotic — DRUGCapsule manufactured without active ingredients.
- Lactobacillus Rhamnosus GG — DIETARY_SUPPLEMENTProbiotic nutritional supplement; Lactobacillus Rhamnosus G
Study Details
To test the efficacy of 6-month LGG compared to placebo in treating Alcoholic Use Disorder (AUD) and liver injury in Alcoholic Hepatitis (AH). And to evaluate the effects of LGG treatment compared to placebo on therapeutic-mechanistic markers of the gut-brain axis and pro-inflammatory activity in patients with AUD and moderate AH
Key Dates
- Start date
- Jun 1, 2022
- Status verified
- Oct 2025
- Primary completion
- Aug 31, 2026
- Completion
- Feb 28, 2027
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Placebo Comparator: Placebo Comparator: Placebo for ProbioticPlacebo capsule that matches the probiotic capsule in appearance will be given once daily for 180 days.
- Active Comparator: Active Comparator: Lactobacillus Rhamnosus GGDietary supplement capsule (Lactobacillus Rhamnosus GG) will be given once daily for 180 days.
Primary Outcome Measure
By lowering heavy drinking to meet the criteria on the responder definitions of abstinence, no heavy drinking days, WHO 1-level, and WHO 2-level reduction [ Time Frame: 180 days ]
Central Contacts
- Amber Jackson, BS CCRP502-852-2905
- Steve Mahanes502-852-1388
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Louisville Hospital | Louisville | Kentucky | 40202 |
Find similar trials in Louisville, KY
By condition
By specialty
By research site
Related Studies
- TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV RiskRecruiting · University of Kentucky · New Haven, Connecticut
- Alcohol Misuse, Gut Microbial Dysbiosis and PrEP Care Continuum: Application and Efficacy of SBIRT InterventionRecruiting · Shirish S Barve · Louisville, Kentucky
- Suvorexant and AlcoholEARLY_PHASE1 · Recruiting · William Stoops · Lexington, Kentucky
- PT150 Drug for Use in Alcohol Use DisorderPHASE1 · Recruiting · Pop Test Oncology LLC · Lexington, Kentucky